Kiadis

Sanofi inks $358M Kiadis takeover to acquire NK-cell platform
Fierce Biotech
Mon, 11/2/20 - 10:48 am
Sanofi
Kiadis
M&A
Sarclisa
natural killer cell therapy
Sanofi Licenses Natural Killer Cancer Program from Kiadis in $987 Million Deal
BioSpace
Thu, 07/9/20 - 12:00 am
Kiadis
Sanofi
natural killer cell therapies
Kiadis dumps phase 3 drug, halves head count in pivot to NK cells
Fierce Biotech
Wed, 11/13/19 - 09:57 am
Kiadis
clinical trials
ATIR101
solid tumors